Nucleic Acid Isolation and Purification Market Size and Growth

Nucleic Acid Isolation and Purification Market reached USD 5,239.0 Million in 2025 and is expected to reach USD 8,376.80 million by 2035, growing with a CAGR of 4.80% during the forecast period 2026-2035.

The Nucleic Acid Isolation and Purification Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Nucleic Acid Isolation and Purification Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type
- Kits
- Reagents
- Instruments

By Technology
- Reagent-Based Isolation and Purification
- Column-Based Isolation and Purification
- Magnetic Bead-Based Isolation and Purification
- Other Technologies

By End Users
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Others

Regional Analysis for Nucleic Acid Isolation and Purification Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:
Both primary and secondary data sources have been used in the global Nucleic Acid Isolation and Purification Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

1. METHODOLOGY AND SCOPE

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product Type

3.2.Market Snippet by Technology

3.3.Market Snippet by End User

3.4.Market Snippet by Region

3.5.DataM CLO Scenario

4. Market Dynamics

4.1.Market Impacting Factors

4.1.1.Drivers

4.1.1.1.Advancement in molecular diagnostics

4.1.1.2.Increasing prevalence of genetic disorders, cancer, infectious diseases, and STDs

4.1.1.3.Increase in government funding for research

4.1.1.4.Rising healthcare expenditures

4.1.2. Restraints

4.1.2.1.High cost of automated instruments

4.1.2.2.Low market penetration

4.1.2.3.Shift from proteomics to genomics

4.1.3.Opportunity

4.1.4.Impact Analysis

5. Industry Analysis

5.1.Porter's Five Forces Analysis

5.2.Supply Chain Analysis

5.3.Regulatory Analysis

5.4.Epidemiology

6. By Product Type

6.1. Introduction

6.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

6.3.Market Attractiveness Index, By Product Type

6.4.Kits

6.4.1.Introduction

6.4.2.Market Size Analysis, and Y-o-Y Growth Analysis (%)

6.5.Reagents

6.6.Instruments

7. By Technology

7.1. Introduction

7.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

7.3.Market Attractiveness Index, By Technology

7.4.Reagent-Based Isolation and Purification

7.4.1. Introduction

7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2025-2033

7.5. Column-Based Isolation and Purification

7.6.Magnetic Bead-Based Isolation and Purification

7.7. Other Technologies

8. By End Users

8.1.Introduction

8.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

8.3.Market Attractiveness Index, By End Users

8.4.Academic and Government Research Institutes

8.4.1.Introduction

8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2025-2033

8.5.Pharmaceutical and Biotechnology Companies

8.6.Contract Research Organizations

8.7.Hospitals and Diagnostic Centers

8.8.Others

9. By Region

9.1. Introduction

9.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.3.Market Attractiveness Index, By Region

9.4.North America

9.4.1. Introduction

9.4.2. Key Region-Specific Dynamics

9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.4.6.1.U.S.

9.4.6.2.Canada

9.4.6.3.Mexico

9.5.Europe

9.5.1. Introduction

9.5.2. Key Region-Specific Dynamics

9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.5.6.1.Germany

9.5.6.2.U.K.

9.5.6.3.France

9.5.6.4.Italy

9.5.6.5.Spain

9.5.6.6.Rest of Europe

9.6.South America

9.6.1. Introduction

9.6.2. Key Region-Specific Dynamics

9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.6.6.1.Brazil

9.6.6.2.Argentina

9.6.6.3.Rest of South America

9.7.Asia Pacific

9.7.1. Introduction

9.7.2. Key Region-Specific Dynamics

9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.7.6.1.China

9.7.6.2.India

9.7.6.3.Japan

9.7.6.4.Australia

9.7.6.5.Rest of Asia Pacific

9.8.Middle East and Africa

9.8.1. Introduction

9.8.2. Key Region-Specific Dynamics

9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1.Competitive Scenario

10.2.Competitor Nucleic Acid Isolation and Purification Strategy Analysis

10.3.Comparative Product Portfolio Analysis

10.4.Market Positioning/Share Analysis

10.5.Mergers and Acquisitions Analysis

11. Company Profiles

11.1.MP Biomedicals *

11.1.1.Company Overview

11.1.2.Product Portfolio and Description

11.1.3.Key Highlights

11.1.4.Financial Overview

11.2.Illumina, Inc.

11.3.General Electric Company

11.4.Sigma-Aldrich

11.5.F.Hoffman-La Roche AG

11.6.Bio-Rad Laboratories

11.7.Promega Corporation

11.8.Danaher Corporation

11.9.Agilent Technologies

11.10.ThermoFisher Scientific

12. DataM Intelligence

12.1.Appendix

12.2.About Us and Services

12.3 Contact Us